GSK Logo

site-logo

Are you a Healthcare Professional? Visit the Healthcare Professional website.

Tyverb

lapatinib

This page is currently being updated and will be available shortly.


additional monitoring symbol

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Tyverb is a registered trademark of the GlaxoSmithKline Group of Companies.

M.C: March 2014: UK/COM/0020/14